A common laboratory dilution is 1 mL of bacteriostatic water per 5mg vial, giving a 5 mg/mL solution
IGF-1 and growth hormone receptor activation controls confirming that AOD-9604 does not engage the classical hGH receptor or elevate IGF-1, distinguishing its mechanism from full-length growth hormone in cell-based reporter systems
The choice between peptides depends on individual goals, tolerance, health status, and whether broad metabolic effects or selective fat targeting is preferred
Research has confirmed no significant effects on serum IGF-1 levels, no negative effect on carbohydrate metabolism, and no immunogenicity with no anti-AOD-9604 antibodies detected in any participants
Progressive Fat Loss Phase (Weeks 4-12): The most significant body composition improvements typically occur between weeks four and twelve of consistent AOD-9604 use
From what the study suggests, AOD 9604 may assist in the transition of these precursor cells into a more mature form